• DCGI Dr V G Somani granted approval for conducting phase 2 and 3 human clinical trials by the SII
• ‘Covishield’ a potential vaccine for COVID-19 has been developed by the University of Oxford
• Before starting the phase 3 trials, the SII has to submit safety data evaluated by the DSMB said a senior government official
Taking the country one step closer towards the....
Tags : Covishield, COVID-19 vaccine, Serum Institute of India, SII, Oxford University, DCGI,